Cardioprotective effects of 44Bu, a newly synthesized compound, in rat heart subjected to ischemia/reperfusion injury

European Journal of Pharmacology

Volumn 640, Issue 1-3, 2010, Pages 117-123

  Basgut, Bilgen ^a   Kayki, Gizem ^b   Bartosova, Ladislava ^c   Ozakca, Isil ^b   Seymen, Aytac ^b   Kandilci, H Burak ^b   Ugur, Mehmet ^b   Turan, Belma ^b   Ozcelikay, A Tanju ^b  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

(Rat); 2 hydroxy 3 (butylamino) propyl 4 (butoxycarbonyl)amino benzoate hydrochloride (44Bu); Infarct size; Ischemia reperfusion injury; Lidocaine; Na+ channel

Indexed keywords

2 HYDROXY 3 (BUTYLAMINO) PROPYL 4 [(BUTOXYCARBONYL)AMINO]BENZOATE HYDROCHLORIDE; CALCIUM; HYDROGEN; LACTATE DEHYDROGENASE; LIDOCAINE; SODIUM; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG; BENZOIC ACID DERIVATIVE; CARDIOTONIC AGENT; COMPOUND 44BU; PROTON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME RELEASE; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; ION EXCHANGE; MALE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RAT; REPERFUSION INJURY; SODIUM CURRENT; ANIMAL; DRUG EFFECTS; ELECTRIC CONDUCTIVITY; HEART; HEART CONTRACTION; IN VITRO STUDY; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; SYNTHESIS; WISTAR RAT;

ANIMALS; BENZOIC ACIDS; CALCIUM; CARDIOTONIC AGENTS; ELECTRIC CONDUCTIVITY; HEART; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PROTONS; RATS; RATS, WISTAR; SODIUM; SODIUM CHANNEL BLOCKERS; BENZOATES; IN VITRO TECHNIQUES;

EID: 77953812439     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.045     Document Type: Article

References (31)

1. + current in rat cardiomyocytes. J. Mol. Cell. Cardiol. 2000, 32:1169-1179.
2. Bartosova L., Frydrych M., Hulakova G., Berankova M., Strnadova V., Mokry P., Brunclik V., Kolevska J., Bebarova M. Efficacy of newly synthesized 44Bu ultrashort-acting, beta-adrenergic antagonist to isoprenaline-induced Tachycardia-comparison with esmolol. Acta Vet. Brno 2004, 73:171-179.
3. Bartosova L., Frydrych M., Hulakova G., Berankova M., Bebarova M., Opatrilova R., Strnadova V., Mokry P., Brunclik V., Kremar J., Bartosikova L., Florian T., Nejas J. Ultrashort bradycardic effect of newly synthesized compounds. Acta Vet. Brno 2006, 75:295-308.
4. Bartosova L., Novak F., Bebarova M., Frydrych M., Brunclik V., Opatrilova R., Kolevska J., Mokry P., Kollar P., Strnadova V., Suchy P. Antiarrhytmic effect of newly synthesized compound 44Bu on model of aconotine-induced arrhythmia-compared to lidocaine. Eur. J. Pharmacol. 2007, 575:127-133.
5. Bebarova M., Matejovic P., Pasek M., Simurdova M., Simurda J. Effect of ajmaline on action potential and ionic currents in rat ventricular myocytes. Gen. Physiol. Biophys. 2005, 24:311-325.
6. Buckler K.J., Vaughan-Jones R.D. Application of a new pH-sensitive fluoroprobe (carboxy-SNARF-1) for intracellular pH measurement in small, isolated cells. Pflugers Arch. 1990, 417:234-239.
7. Buja L.M. Myocardial ischemia and reperfusion injury. Cardiovasc. Pathol. 2005, 14:170-175.
8. Cargnoni A., Condorelli E., Ceconi C., Curello S., Albertini A., Ferrari R. Mechanism of myocardial protective action of dilazep during ischaemia and reperfusion. Pharmacol. Res. Commun. 1987, 19:341-357.
9. Dhalla N.S., Saini H.K., Tappia P.S., Sethi R., Mengi S.A., Gupta S.K. Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease. J. Cardiovasc. Med. 2007, 8:238-250.
10. + exchange blokers EIPA, cariporide and eniporide. Mol. Cell. Biochem. 2003, 250:47-54.
11. + overload in rat heart. Mol. Cell. Biochem. 2007, 297:101-110.
12. Iwai T., Tanonaka K., Inoue R., Kasahara S., Motegi K., Nagaya S., Takeo S. Sodium accumulation during ischemia induces mitochondrial damage in perfused rat heart. Cardiovasc. Res. 2002, 55:141-149.
13. Ju Y.K., Saint D.A., Gage P.W. Effects of lignocaine and quinidine on the persistent sodium current in rat ventricular myocytes. Br. J. Pharmacol. 1992, 107:311-316.
14. Lee K.S., Hume J.R., Giles W., Brown A.M. Sodium current depression by lidocaine and quinidine in isolated ventricular cells. Nature 1981, 291:325-327.
15. Leem C.H., Lagadic-Gossmann D., Vaughan-Jones R.D. Characterization of intracellular pH regulation in the guinea-pig ventricular myocyte. J. Physiol. 1999, 517:159-180.
16. Lefer A.M., Polansky E.W., Bianchi C.P., Narayan S. Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat. Basic. Res. Cardiol. 1979, 74:555-567.
17. Moens A.L., Claeys M.J., Timmermans J.P., Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int. J. Cardiol. 2005, 100:179-190.
18. Nayler W.G., Ferrari R., Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am. J. Cardiol. 1980, 46:242-248.
19. Nayler W.G. Basic mechanisms involved in the protection of the ischaemic myocardium. The role of calcium antagonists. Drugs 1991, 42:21-27.
20. Powers S.K., Murlasits Z., Wu M., Kavazis A.N. Ischemia-reperfusion-induced cardiac injury: a brief review. Med. Sci. Sports Exerc. 2007, 39:1529-1536.
21. 1-Adrenoreceptor subtype blockade on ischemia-reperfusion injury. Jpn. Circ. 1997, 61:927-935.
22. Takeo S., Tanonaka K., Hayashi M., Yamamoto K., Liu J., Kamiyama T., Yamaguchi N., Miura A., Natsukawa T. A possible involvement of sodium channel blockade of class-I-type antiarrhytmic agents in postischemic contractile recovery of isolated, perfused hearts. J. Pharmacol. Exp. Ther. 1995, 273:1403-1409.
23. 2+ overload in reperfused ischemic myocardium. Annu. Rev. Physiol. 1990, 52:543-559.
24. Tanonaka K., Takasaki A., Kajiwara H., Takeo S. Contribution of sodium channel and sodium/hydrogen exchanger to sodium accumulation in the ischemic myocardium. Gen. Pharmacol. 2000, 34:167-174.
25. Turan N., Csonka C., Csont T., Giricz Z., Fodor G., Bencsik P., Gyöngyösi M., Cakici I., Ferdinandy P. The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts. Cardiovasc. Res. 2006, 70:384-390.
26. + during myocardial ischemia: consequences for post-ischemic recovery. J. Moll. Cell. Cardiol. 1997, 29:85-96.
27. 2+ exchanger during the first minutes of reperfusion results in continued myocardial stunning. Eur. J. Pharmacol. 2007, 572:1-11.
28. i during ischemia and reperfusion in the rat heart-underlying mechanisms. Pflügers Arch. Eur. J. Physiol. 2007, 454:903-912.
29. + exchanger during ischemia and preconditioning in the isolated rat heart. Cir. Res. 1999, 85:723-730.
30. Yaras N., Ugur M., Ozdemir S., Gurdal H., Purali N., Lacampagne A., Vassort G., Turan B. Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart. Diabetes 2005, 54:3082-3088.
31. Zhang M., Xu Y.J., Saini H.K., Turan B., Liu P.P., Dhalla N.S. Pentoxifylline attenuates cardiac dysfunction and reduces TNF-α level in ischemic-reperfused heart. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H832-H839.